Evercore ISI lowered the firm’s price target on GE HealthCare (GEHC) to $85 from $98 and keeps an Outperform rating on the shares as part of the firm’s medical technology and life science tools Q1 preview.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare recommends shareholders reject Potemkin’s ‘mini-tender’ offer
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 29
- GE HealthCare announces industrial role in new COMPASS consortium
- GE HealthCare to showcase cardiology portfolio at ACC.26
- GE HealthCare receives FDA clearance for Photonova Spectra